SAT0255 A randomized, placebo-controlled, double-blind, ascending-dose, safety study of CC-220 in subjects with systemic lupus erythematosus

V. Werth, Douglas R. Hough, Shimon Korish et al.|Annals of the Rheumatic Diseases|2017

Cited by 6